SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-008768
Filing Date
2022-01-13
Accepted
2022-01-13 17:16:02
Documents
16
Period of Report
2022-01-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d259937d8k.htm   iXBRL 8-K 31154
2 EX-1.1 d259937dex11.htm EX-1.1 212041
3 EX-4.1 d259937dex41.htm EX-4.1 66578
4 EX-5.1 d259937dex51.htm EX-5.1 12457
8 GRAPHIC g259937g0113130904312.jpg GRAPHIC 2529
  Complete submission text file 0001193125-22-008768.txt   530873

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20220112.xsd EX-101.SCH 2888
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20220112_lab.xml EX-101.LAB 18138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20220112_pre.xml EX-101.PRE 11405
10 EXTRACTED XBRL INSTANCE DOCUMENT d259937d8k_htm.xml XML 3350
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 22529782
SIC: 2836 Biological Products, (No Diagnostic Substances)